Phase 3 study demonstrates that neo-adjuvant chemoradiotherapy plus surgery, in esophageal or esophago-gastric-junction carcinoma, results in a higher survival rate than surgery treatment alone.
Monday, 11 June 2012
Treating Esophageal Cancer With Preoperative Chemoradiotherapy | MedIndia
Treating Esophageal Cancer With Preoperative Chemoradiotherapy | MedIndia
Phase 3 study demonstrates that neo-adjuvant chemoradiotherapy plus surgery, in esophageal or esophago-gastric-junction carcinoma, results in a higher survival rate than surgery treatment alone.
http://www.medindia.net/news/healthwatch/treating-esophageal-cancer-with-preoperative-chemoradiotherapy-102516-1.htm#
Phase 3 study demonstrates that neo-adjuvant chemoradiotherapy plus surgery, in esophageal or esophago-gastric-junction carcinoma, results in a higher survival rate than surgery treatment alone.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment